Prozac, Ritalin, Cognitive Enhancement, and the power of a snappy title

Let it be known that Sci, like many a young, bright-eyed little scientist, tries to keep up on her reading. TRIES is the operative word, but every week Sci gets the Tables of Contents for all the major journals in her field (and all the major ones in her subdisciple) emailed straight to her for her perusal. She scans the title lists, searching for things that are cool in her field, cool to blog, or that might indicate a scoopage of her work (hey, it happens).
And it was in one of these perusals that I came across this article. And this article is on a subject that needs to be blogged. But this article also says a lot about the “selling” of a scientific paper to a high-ranking journal. Biological Psychiatry, the journal in which this paper was published, has a pretty decent impact factor (8.67), and in Sci’s field, is considered to be a pretty hot publication venue.
But before I go into that, let’s take a look at this paper: Steiner et al. “Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: Concerns for use of cognitive enhancers?” Biological Psychiatry, 2010.
cognitive enhancer1.jpg
Sci would like to start by noting that doing an image search for “cognitive enhancer” yields some surprisingly boring results. I was really hoping for something like this:
cognitive enhance2.jpg
Oh well.

Continue reading